Business Context and Reporting Period
Company: Mustang Bio, Inc. (MBIO)
Filing Type: Form 8-K (Current Report)
Date of Report: September 10, 2024
Reporting Period: Event-based report regarding Nasdaq listing compliance status.
Key Financial Metrics
This filing does not contain specific financial statements, revenue, profit, cash flow, or debt figures. The report focuses exclusively on regulatory compliance regarding stockholders' equity.
- Stockholders' Equity Requirement: $2.5 million (Nasdaq Listing Rule 5550(b)).
- Compliance Status: Non-compliant as of September 9, 2024.
Material Changes
The primary material change is the formal notification from the Nasdaq Staff on September 10, 2024, determining that the Company's securities will be delisted due to continued failure to meet the $2.5 million stockholders' equity requirement. This follows an extension granted on May 16, 2024, which expired without the Company demonstrating compliance.
Outlook, Risks, and Management Commentary
- Management Action: The Company intends to timely request a hearing before the Nasdaq Hearings Panel. This request will stay further delisting action pending the hearing and any potential extension granted thereafter.
- Trading Status: The notification and non-compliance do not have an immediate effect on trading; common stock will continue to trade on the Nasdaq Capital Market under the symbol "MBIO."
- Risks and Uncertainties: There is no assurance that the Panel will grant the request for continued listing or that the Company will be able to evidence compliance within any extension period. The filing includes standard forward-looking statement disclaimers regarding the uncertainty of future performance and regulatory outcomes.
Investor Verification Checklist
- Verify the current stockholders' equity balance in the Company's most recent 10-Q or 10-K to understand the magnitude of the deficit.
- Monitor the status of the hearing request before the Nasdaq Hearings Panel and any subsequent rulings.
- Review the Company's capital raise plans or other strategies to regain compliance with the $2.5 million equity threshold.
- Check for any subsequent 8-K filings regarding the outcome of the hearing or changes in listing status.